BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTB
3701
Connect Biopharma Holdings
CNTB
$127M
| $6.75M | ﹤0.01% |
2,236,392
+92,632
| +4% | +$391K |
|
3702
Spyre Therapeutics
SYRE
$8.54B
| $6.72M | ﹤0.01% |
116,872
-3,067
| -3% | -$258K |
|
3703
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
$821M
| $6.71M | ﹤0.01% |
275,000
| – | – |
|
3704
Montauk Renewables
MNTK
$243M
| $6.68M | ﹤0.01% |
596,491
+354
| +0.1% | +$3.7K |
|
3705
Blend Labs
BLND
$431M
| $6.67M | ﹤0.01% |
1,169,796
+774,425
| +196% | +$6M |
|
|
VTYX
3706
DELISTED
Ventyx Biosciences
VTYX
| $6.67M | ﹤0.01% |
491,336
-3,366
| -0.7% | -$45K |
|
|
RPTX
3707
DELISTED
Repare Therapeutics
RPTX
| $6.66M | ﹤0.01% |
467,311
+8,680
| +2% | +$129K |
|
|
SQZ
3708
DELISTED
SQZ Biotechnologies Company
SQZ
| $6.64M | ﹤0.01% |
1,381,455
-32,415
| -2% | -$206K |
|
|
LOTZ
3709
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $6.63M | ﹤0.01% |
4,839,190
-122,264
| -2% | -$231K |
|
3710
Gildan
GIL
$10.3B
| $6.62M | ﹤0.01% |
176,520
-871,466
| -83% | -$34.2M |
|
3711
Western Midstream Partners
WES
$19.2B
| $6.61M | ﹤0.01% |
261,945
+25,249
| +11% | +$623K |
|
3712
OR Royalties Inc
OR
$5.58B
| $6.59M | ﹤0.01% |
+500,000
| New | +$6.21M |
|
|
AMPE
3713
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $6.58M | ﹤0.01% |
46,654
+205
| +0.4% | +$29.9K |
|
3714
Algonquin Power & Utilities
AQN
$4.49B
| $6.55M | ﹤0.01% |
422,186
+421,457
| +57,813% | +$6.08M |
|
3715
Vita Coco
COCO
$3.82B
| $6.53M | ﹤0.01% |
729,130
+62,355
| +9% | +$652K |
|
3716
iBio
IBIO
$69.5M
| $6.52M | ﹤0.01% |
30,441
-512
| -2% | -$107K |
|
3717
Nano X Imaging
NNOX
$68.2M
| $6.51M | ﹤0.01% |
601,033
-7,501
| -1% | -$80.1K |
|
|
ALPN
3718
DELISTED
Alpine Immune Sciences Inc
ALPN
| $6.49M | ﹤0.01% |
723,138
-5,710
| -0.8% | -$49.4K |
|
|
CDAK
3719
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $6.49M | ﹤0.01% |
1,034,195
-14,616
| -1% | -$91.8K |
|
3720
Farmers & Merchants Bancorp
FMAO
$459M
| $6.48M | ﹤0.01% |
179,263
-534
| -0.3% | -$17.8K |
|
|
SBDS
3721
DELISTED
Solo Brands Inc
SBDS
| $6.47M | ﹤0.01% |
18,967
+222
| +1% | +$98.2K |
|
3722
Garrett Motion
GTX
$5.81B
| $6.46M | ﹤0.01% |
898,030
+16,089
| +2% | +$115K |
|
3723
Warby Parker
WRBY
$3.28B
| $6.46M | ﹤0.01% |
190,983
+17,340
| +10% | +$561K |
|
|
QTNT
3724
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $6.46M | ﹤0.01% |
134,535
-1,215
| -0.9% | -$72.6K |
|
3725
Black Diamond Therapeutics
BDTX
$96.8M
| $6.45M | ﹤0.01% |
2,329,164
+80,697
| +4% | +$295K |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.